Grant: Engage Grants Program
Ryerson University
$25,000.00
A novel process for the decarboxylation, selective extraction, and purification of cannabidiol (CBD) from hemp
EF 2016-17
Résumé
BELEAVE Inc plans to produce high-quality medicinal plant extracts to treat patients suffering from a variety of health issues, including pain, inflammation and tissue loss in arthritis. Plant-based prescriptions, and even selective extracts from medicinal plant tissues, contain a diversity of pharmaceutically relevant compounds including terpenophenols that must be extracted, isolated and identified for drug standardization, and to evaluate clinical applications. There is a need to decarboxylate cannabidiol (CBD) in an oven, extract the compound by selective mixtures of potable ethanol and water, and to separate the CBD from other cannabinoids by ion exchange chromatography. Unless the CBD can be routinely extracted, isolated, identified, and evaluated at precise doses, attribution of medicinal activity to specific compounds in the treatment of particular diseases and the production of useful biopharmaceuticals will be difficult. Thus, there is an urgent need to understand the extraction and separation of CBD and establish a novel and effective strategy for the extraction and isolation of terpenophenol compounds from plant tissues using potable solvents to yield purified products for the quantification of terpenophenols such as cannabidiol (CBD). CBD has a similar molecular mass to that of some other key terpenophenols, however CBD has two exposed hydroxyl groups that might be exploited to separate it from other terpenophenols by partition between polar solvents or anion exchange chromatography. The CBD from floral tissues of non-psychoactive, medicinal hemp cultivars will be decarboxlyted in an oven by a range of temperatures, the solubility (and precipitation point) for the extraction of CBD from hemp will be determined with a range of water/ethanol fractions, and CBD retention by strong or weak ion exchange and C18 reversed phase chromatography for isolation will be examined to develop areliable strategy for extracting and identifying terpenophenols such as CBD.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
505937-2016
Name nom
Marshall, John
Department département
Chemistry and Biology
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3503
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Separation methods
Research subject fr
Méthodes de séparation
Partie
1
Nb partie
1
Application title
A novel process for the decarboxylation, selective extraction, and purification of cannabidiol (CBD) from hemp
Keyword
NSERC
Application summary
BELEAVE Inc plans to produce high-quality medicinal plant extracts to treat patients suffering from a variety of health issues, including pain, inflammation and tissue loss in arthritis. Plant-based prescriptions, and even selective extracts from medicinal plant tissues, contain a diversity of pharmaceutically relevant compounds including terpenophenols that must be extracted, isolated and identified for drug standardization, and to evaluate clinical applications. There is a need to decarboxylate cannabidiol (CBD) in an oven, extract the compound by selective mixtures of potable ethanol and water, and to separate the CBD from other cannabinoids by ion exchange chromatography. Unless the CBD can be routinely extracted, isolated, identified, and evaluated at precise doses, attribution of medicinal activity to specific compounds in the treatment of particular diseases and the production of useful biopharmaceuticals will be difficult. Thus, there is an urgent need to understand the extraction and separation of CBD and establish a novel and effective strategy for the extraction and isolation of terpenophenol compounds from plant tissues using potable solvents to yield purified products for the quantification of terpenophenols such as cannabidiol (CBD). CBD has a similar molecular mass to that of some other key terpenophenols, however CBD has two exposed hydroxyl groups that might be exploited to separate it from other terpenophenols by partition between polar solvents or anion exchange chromatography. The CBD from floral tissues of non-psychoactive, medicinal hemp cultivars will be decarboxlyted in an oven by a range of temperatures, the solubility (and precipitation point) for the extraction of CBD from hemp will be determined with a range of water/ethanol fractions, and CBD retention by strong or weak ion exchange and C18 reversed phase chromatography for isolation will be examined to develop areliable strategy for extracting and identifying terpenophenols such as CBD.